Smith Deane, Grossi Eugene A, Balsam Leora B, Ursomanno Patricia, Rabinovich Annette, Galloway Aubrey C, DeAnda Abe
Department of Cardiothoracic Surgery, New York University-Langone Medical Center, New York, New York.
Aorta (Stamford). 2013 Sep 1;1(4):219-26. doi: 10.12945/j.aorta.2013.13-035. eCollection 2013 Sep.
Recent Society of Thoracic Surgeons and Society of Cardiovascular Anesthesiologists (STS/SCA) guidelines highlight the safety of blood conservation strategies in routine cardiac surgery. We evaluated the feasibility and impact of such a program in complex aortic surgery.
Between March 2010 and October 2011, 63 consecutive aortic replacement procedures were performed: aortic root (n = 17; 27%), ascending aorta (n = 15; 23.8%), aortic arch (n = 19; 30.2%), descending aorta (n = 8; 12.7%), and thoracoabdominal aorta (n = 4; 6.3%). Aortic dissections were present in 32 patients. A multidisciplinary approach to blood conservation included minimal perioperative crystalloid, small priming circuits, hemoconcentration, meticulous hemostasis, and tolerance of postoperative anemia (hemoglobin of ≥ 7mg/dL).
Operative mortality was 11.1%. Multivariate predictors of mortality were low preoperative hematocrit (HCT, P = 0.05) and endocarditis (P = 0.021). Seventy-four percent of patients required no intraoperative packed red blood cell (pRBC) transfusion. For nondissection patients, 80.6% required ≤ 1 U of intraoperatively compared to 54.3% in STS benchmark data (P < 0.0001). During the hospital stay, 24 patients (39%) received no pRBCs and 34 patients (54%) received ≤ 1 U of pRBCs. Multivariate predictors of pRBC transfusion were low preoperative HCT (P = 0.04) and cardiopulmonary bypass time (P = 0.01). Discharge hemoglobin/HCT values were 8.7/26.3 compared to preoperative 12.1/35.5 (p < 0.001). Complications were absent in 94% (32/34) of patients receiving ≤1 U compared to 59% (17/29) in patients who received ≥ 2 U (P = 0.001).
These findings demonstrate that a perioperative blood conservation management strategy can be extended to complex aortic surgery and is associated with better clinical outcomes.
近期胸外科医师协会和心血管麻醉医师协会(STS/SCA)指南强调了常规心脏手术中血液保护策略的安全性。我们评估了该方案在复杂主动脉手术中的可行性和影响。
2010年3月至2011年10月期间,连续进行了63例主动脉置换手术:主动脉根部(n = 17;27%)、升主动脉(n = 15;23.8%)、主动脉弓(n = 19;30.2%)、降主动脉(n = 8;12.7%)和胸腹主动脉(n = 4;6.3%)。32例患者存在主动脉夹层。多学科血液保护方法包括围手术期最小化晶体液、小型预充回路、血液浓缩、细致止血以及对术后贫血的耐受性(血红蛋白≥7mg/dL)。
手术死亡率为11.1%。死亡率的多因素预测指标为术前血细胞比容(HCT)低(P = 0.05)和心内膜炎(P = 0.021)。74%的患者术中无需输注浓缩红细胞(pRBC)。对于无夹层患者,80.6%术中所需pRBC≤1单位,而STS基准数据中的这一比例为54.3%(P < 0.0001)。住院期间,24例患者(39%)未接受pRBC输注,34例患者(54%)接受pRBC≤1单位。pRBC输注的多因素预测指标为术前HCT低(P = 0.04)和体外循环时间长(P = 0.01)。出院时血红蛋白/HCT值为8.7/26.3,而术前为12.1/35.5(p < 0.001)。接受≤1单位pRBC输注的患者中94%(32/34)无并发症,而接受≥2单位pRBC输注的患者中这一比例为59%(17/29)(P = 0.001)。
这些结果表明,围手术期血液保护管理策略可扩展至复杂主动脉手术,并与更好的临床结局相关。